Yoni Falkson

Yoni Falkson is a seasoned professional with a strong educational background. He holds an MBA from NYU Stern School of Business and pursued studies in Economics and Psychology at Cornell University. With an impressive academic foundation, Yoni has ventured into various roles within the pharmaceutical and healthcare industry, showcasing his diverse skill set and expertise.

Yoni's career highlights include serving as the Chief Operating Officer at Gilgamesh Pharmaceuticals and holding senior positions at Regeneron, where he led new product marketing and planning initiatives. His experience extends to serving on the board and offering strategic guidance at Gilgamesh Pharmaceuticals.

Moreover, Yoni was a key figure in the success of Perception Neuroscience, which was acquired by Atai Life Sciences. He also co-founded SpringWorks Therapeutics, showing his entrepreneurial spirit and innovative approach in the biotech sector. Yoni's tenure at Pfizer equipped him with valuable insights into global commercial strategies, product planning, pricing, and reimbursement within the pharmaceutical landscape.

Throughout his accomplished career, Yoni Falkson has been recognized for his strategic acumen, leadership capabilities, and contributions to the pharmaceutical industry. His versatile background and extensive experience make him a sought-after professional in the healthcare and biotech domains.